πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8026284

Enterically coated cystamine, cysteamine and derivatives thereof

The Regents of the University of California Β· Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8026263

Methods for inhibiting neoproliferative changes in blood vessel walls

The Regents of the University of California Β· Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8022052

Inhibition of PPAR gamma expression by specific osteogenic oxysterols

The Regents of the University of California Β· Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8021644

Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-

The Regents of the University of California Β· Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8021673

Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

The Regents of the University of California Β· Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8022040

Hydroxyapatite-binding peptides for bone growth and inhibition

The Regents of the University of California Β· Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8017135

Lipid-drug conjugates for local therapy of eye diseases

The Regents of the University of California Β· Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8012739

Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase p

The Regents of the University of California Β· Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8008353

Methods for modulating macrophage proliferation using polyamine analogs

The Regents of the University of California Β· Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8008308

Phosphonate compounds

The Regents of the University of California Β· Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8007778

Use of calcium binding proteins to improve cardiac contractile function

The Regents of the University of California Β· Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8008510

Metalloprotein inhibitors

The Regents of the University of California Β· Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8003693

Modulation of anxiety through blockade of anandamide hydrolysis

The Regents of the University of California Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7998481

Modulation of NKG2D for treating or preventing solid organ allograft rejection

The Regents of the University of California Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7998923

Bioactivation of particles

The Regents of the University of California Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7998928

Method of treatment of type-1 diabetes with a humanin analogue

The Regents of the University of California Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7999079

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7994143

Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nu

The Regents of the University of California Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7993866

Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen

The Regents of the University of California Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7993865

Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen

The Regents of the University of California Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7993867

Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen

The Regents of the University of California Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7994226

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

The Regents of the University of California Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7994132

Peptides for treatment of scleroderma

The Regents of the University of California Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7985783

Aldehyde tags, uses thereof in site-specific protein modification

The Regents of the University of California Β· Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted